Association between monovalent influenza A (H1N1) pdm09 vaccine and pneumonia among the elderly in the 2009-2010 season in Japan: A case-control study

被引:5
|
作者
Kondo, Kyoko [1 ]
Suzuki, Kanzo [2 ]
Washio, Masakazu [3 ]
Ohfuji, Satoko [1 ]
Fukushima, Wakaba [1 ]
Maeda, Akiko [1 ]
Hirota, Yoshio [1 ]
机构
[1] Osaka City Univ, Fac Med, Dept Publ Hlth, Osaka 558, Japan
[2] Nagoya City Univ, Sch Nursing, Nagoya, Aichi, Japan
[3] St Marys Coll, Dept Community Hlth & Clin Epidemiol, Kurume, Fukuoka, Japan
关键词
effectiveness; elderly people; matched case-control study; monovalent influenza A (H1N1) pdm09 vaccine; pneumonia; H1N1pdm; monovalent influenza A (H1N1) pdm09; TIV; trivalent seasonal influenza vaccine; COPD; chronic obstructive pulmonary disease; ADL; activities of daily living; OR; odds ratio; CI; confidence interval; COMMUNITY-ACQUIRED PNEUMONIA; RISK;
D O I
10.1080/21645515.2015.1016668
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
We investigated the association between monovalent influenza A (H1N1) pdm09 (H1N1pdm) vaccine and pneumonia in elderly people. Study design was a hospital-based, matched case-control study. Cases comprised patients =65 years old who had been newly diagnosed with pneumonia. For each case, 2 controls were defined as individuals with other diseases (not pneumonia) who were matched by sex, age, entry date, and the visited hospital. Study period was the interval from 1 September 2009 until 30 September 2010. Because a pandemic of influenza A (H1N1) occurred during study period, we analyzed selected subjects who had enrolled during the influenza A (H1N1) pandemic. We calculated the odds ratios (ORs) and 95% confidence intervals (CIs) for pneumonia in H1N1pdm-vaccinated subjects compared with unvaccinated subjects using a conditional logistic regression model to assess the association between H1N1pdm vaccine and pneumonia. The subjects during the period of the influenza A (H1N1) pandemic were 20 cases and 40 controls. Subjects who had received H1N1pdm vaccine showed a significantly decreased OR for pneumonia (OR = 0.10, 95% CI = 0.01-0.98) compared with unvaccinated subjects. In conclusion, H1N1pdm vaccination may have prevented pneumonia among the elderly during the 2009-2010 influenza A (H1N1) pandemic in Japan.
引用
收藏
页码:1088 / 1093
页数:6
相关论文
共 50 条
  • [1] Association between monovalent influenza A (H1N1) pdm09 vaccine and pneumonia among the elderly in the 20092010 season in Japan: A case-control study (vol 11, pg 1088, 2015)
    Kondo, Kyoko
    Suzuki, Kanzo
    Washio, Masakazu
    Ohfuji, Satoko
    Fukushima, Wakaba
    Maeda, Akiko
    Hirota, Yoshio
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2015, 11 (10) : 2510 - 2510
  • [2] A DESCRIPTIVE STUDY OF PANDEMIC INFLUENZA A(H1N1)PDM09 IN BRAZIL, 2009-2010
    Rossetto, Erika Valeska
    de Albuquerque Luna, Expedito Jose
    REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO, 2016, 58 : 78
  • [3] Effectiveness of the monovalent influenza A(H1N1)2009 vaccine in Navarre, Spain, 2009-2010: Cohort and case-control study
    Castilla, Jesus
    Moran, Julio
    Martinez-Artola, Victor
    Fernandez-Alonso, Mirian
    Guevara, Marcela
    Garcia Cenoz, Manuel
    Reina, Gabriel
    Alvarez, Nerea
    Arriazu, Maite
    Elia, Fernando
    Salcedo, Esther
    Barricarte, Aurelio
    VACCINE, 2011, 29 (35) : 5919 - 5924
  • [4] Prevailing effectiveness of the 2009 influenza A(H1N1) pdm09 vaccine during the 2010/11 season in Sweden
    Widgren, K.
    Magnusson, M.
    Hagstam, P.
    Widerstrom, M.
    Ortqvist, A.
    Einemo, I. M.
    Follin, P.
    Lindblom, A.
    Makitalo, S.
    Wik, O.
    Osterlund, A.
    Grunewald, M.
    Uhnoo, I.
    Linde, A.
    EUROSURVEILLANCE, 2013, 18 (15): : 37 - 44
  • [5] Database linkage for surveillance of the influenza A(H1N1)pdm09 pandemic in Brazil, 2009-2010
    Rossetto, Erika Valeska
    de Albuquerque Luna, Expedito Jose
    CADERNOS DE SAUDE PUBLICA, 2016, 32 (07):
  • [6] Molecular Epidemiology of Influenza A(H1N1)pdm09 Viruses from Pakistan in 2009-2010
    Aamir, Uzma Bashir
    Badar, Nazish
    Mehmood, Muhammad Rashid
    Nisar, Nadia
    Suleman, Rana Muhammad
    Shaukat, Shehzad
    Sharif, Salman
    Kamran, Jaleel
    Zaidi, Syed Sohail Zahoor
    Kazi, Birjees Mazher
    Gubareva, Larisa
    Xu, Xiyan
    Garten, Rebecca
    Klimov, Alexander
    PLOS ONE, 2012, 7 (08):
  • [7] Factors Associated With Uptake of the Influenza A(H1N1)pdm09 Monovalent Pandemic Vaccine in K-12 Public Schools, Maine 2009-2010
    Lorick, Suchita A.
    Goldberg, Lisa
    Zhang, Fan
    Birkhimer, Nancy
    Dube, Nancy
    Dutram, Kay
    Hubley, Teresa
    Tipton, Meredith
    Basurto-Davila, Ricardo
    Graitcer, Sam
    Mills, Dora Anne
    JOURNAL OF PUBLIC HEALTH MANAGEMENT AND PRACTICE, 2015, 21 (02): : 186 - 195
  • [8] Effectiveness of the Influenza A(H1N1)pdm09 Vaccine in Adults Recommended for Annual Influenza Vaccination: A Case-Control Study
    Gefenaite, Giedre
    Tacken, Margot
    Bos, Jens
    Stirbu-Wagner, Irina
    Korevaar, Joke C.
    Stolk, Ronald P.
    Wolters, Bert
    Bijl, Marc
    Postma, Maarten J.
    Wilschut, Jan
    Nichol, Kristin L.
    Hak, Eelko
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 357 - 358
  • [9] Immunogenicity of a monovalent influenza A(H1N1)pdm09 vaccine in patients with hematological malignancies
    Ide, Yuichiro
    Imamura, Yutaka
    Ohfuji, Satoko
    Fukushima, Wakaba
    Ide, Saburo
    Tsutsumi, Chiyo
    Koga, Masahisa
    Maeda, Kazuhiro
    Hirota, Yoshio
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2014, 10 (08) : 2387 - 2394
  • [10] Evaluation of Diagnostic and Therapeutic Approaches for Suspected Influenza A(H1N1)pdm09 Infection, 2009-2010
    Vijayan, Vini
    Jing, Jennie
    Zangwill, Kenneth M.
    EMERGING INFECTIOUS DISEASES, 2012, 18 (09) : 1414 - 1421